INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • February 19th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of October 27, 2020, by and among Longboard Pharmaceuticals, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and, solely for purposes of Sections 1.5, 1.19, 4, 5.5 and 6, Arena Pharmaceuticals, Inc. (“ARNA”).
INDEMNITY AGREEMENTIndemnification Agreement • February 19th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS INDEMNITY AGREEMENT (this “Agreement”) dated as of ___________ _____, 20__, is made by and between LONGBOARD PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and _________________ (“Indemnitee”).
SERVICES AGREEMENTServices Agreement • February 19th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS SERVICES AGREEMENT (this “Agreement”), effective as of October 27, 2020 (the “Effective Date”) by and between Arena Pharmaceuticals, Inc., a Delaware corporation (“Arena”) and Longboard Pharmaceuticals, Inc., a Delaware corporation (“Longboard”). Longboard and Arena are referred to individually as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENTLicense Agreement • February 19th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”) is entered into as of October 27, 2020 (the “Effective Date”), by and between LONGBOARD PHARMACEUTICALS, INC., a Delaware corporation (“Licensee”), and ARENA PHARMACEUTICALS INC., a Delaware corporation (“Licensor”).
Royalty Purchase AgreementRoyalty Purchase Agreement • February 19th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis Royalty Purchase Agreement (the “Agreement”), dated as of October 27, 2020, is by and between Arena Pharmaceuticals, Inc. (“Parent”), 356 Royalty Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“356”), and Longboard Pharmaceuticals, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (the “Company”). Capitalized terms used but not defined herein shall have the meaning ascribed to such terms in that certain Transaction Agreement, dated as of December 28, 2016, by and among 356, Eisai Inc. and Eisai Co., Ltd. (the “Transaction Agreement”).